Fastinov Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.81M

  • Investors
  • 3

Fastinov General Information

Description

Developer of antimicrobial susceptibility test technology kits designed to check for life-threatening bacterial infections directly from blood cultures. The company's technology offers early detection of microbial cell lesions or metabolic changes, relying on fluorochromes that target specific changes that can be identified through flow cytometer analysis, enabling physicians to decide which drugs to prescribe to their patients for microbial infection treatments.

Contact Information

Website
www.fastinov.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • UPTEC Corporate Campus Science and Technology Park
  • Rua Alfredo Allen, Number 455/461
  • Porto, 4200-135
  • Portugal
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Manufacturing, Digital Health, HealthTech
Corporate Office
  • UPTEC Corporate Campus Science and Technology Park
  • Rua Alfredo Allen, Number 455/461
  • Porto, 4200-135
  • Portugal

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fastinov Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 04-Sep-2023 $3.81M Completed Generating Revenue
7. Secondary Transaction - Private 01-Jul-2022 Completed Generating Revenue
6. Grant 30-Apr-2018 Completed Generating Revenue
5. Accelerator/Incubator 28-Mar-2018 Completed Generating Revenue
4. Grant 08-Jun-2016 Completed Generating Revenue
3. Seed Round 29-Sep-2015 Completed Generating Revenue
2. Grant 01-Jan-2013 $4.13M Completed Startup
1. University Spin-Out 01-Jan-2013 Completed Startup
To view Fastinov’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Fastinov Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Fastinov Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4476357-A1 Antimicrobial susceptibility Pending 10-Feb-2022
US-20250154554-A1 Antimicrobial susceptibility Pending 10-Feb-2022
WO-2023152218-A1 Antimicrobial susceptibility Inactive 10-Feb-2022
EP-3630997-A1 Improved therapeutic drug monitoring Active 02-Jun-2017
US-20200190554-A1 Improved therapeutic drug monitoring Active 02-Jun-2017 C12Q1/18
To view Fastinov’s complete patent history, request access »

Fastinov Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fastinov Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Explorer Investments PE/Buyout Minority
Quilaban Corporation Minority
University of Porto University
To view Fastinov’s complete investors history, request access »

Ready to get started?

Request a free trial

Fastinov FAQs

  • When was Fastinov founded?

    Fastinov was founded in 2013.

  • Where is Fastinov headquartered?

    Fastinov is headquartered in Porto, Portugal.

  • What is the size of Fastinov?

    Fastinov has 8 total employees.

  • What industry is Fastinov in?

    Fastinov’s primary industry is Diagnostic Equipment.

  • Is Fastinov a private or public company?

    Fastinov is a Private company.

  • What is the current valuation of Fastinov?

    The current valuation of Fastinov is .

  • What is Fastinov’s current revenue?

    The current revenue for Fastinov is .

  • How much funding has Fastinov raised over time?

    Fastinov has raised $4.32M.

  • Who are Fastinov’s investors?

    Explorer Investments, Quilaban, and University of Porto have invested in Fastinov.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process